NCT05160922 2026-03-30Crizotinib Continuation Clinical StudyPfizerPhase 4 Active not recruiting27 enrolled
NCT01524926 2023-12-11CREATEEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed582 enrolled